Home › Funds › TCG Crossover Management, LLC › GLUE

TCG Crossover Management, LLC position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

TCG Crossover Management, LLC reported holding 4,622,151 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$111.9M, representing 2.69% of its reported portfolio and ranking #11 among its reported holdings. TCG Crossover Management, LLC has disclosed GLUE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)4.62M sh
Reported value held$111.86M
Portfolio Weight2.69%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's GLUE position evolved

TCG Crossover Management, LLC first disclosed a stake in GLUE in Q4 2025 at 4,622,151 shares (US$72.5M). The position peaked in Q2 2026 at 4,622,151 shares, worth US$111.9M. Across 3 filings, TCG Crossover Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 4,622,151 shares valued at US$111.9M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.62M $72.48M New
Q1 2026 4.62M $76.03M Hold
Q2 2026 4.62M $111.86M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), Vestal Point Capital, LP (US$111.3M), BVF INC/IL (US$108.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has TCG Crossover Management, LLC held GLUE?

TCG Crossover Management, LLC has disclosed GLUE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is TCG Crossover Management, LLC's current position in GLUE?

As of Q2 2026, TCG Crossover Management, LLC holds 4.62M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $111.86M, representing 2.69% of its reported portfolio and ranking #11.

Has TCG Crossover Management, LLC been buying or selling GLUE?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in GLUE. The position peaked in Q2 2026 at 4.62M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, Vestal Point Capital, LP, BVF INC/IL, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.